As of Sep 22
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 16.50, with a high estimate of 40.00 and a low estimate of 12.00. The median estimate represents a +211.91% increase from the last price of 5.29.
The current consensus among 4 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.